4th RNA Editing Summit

The 4^th RNA Editing Summit welcomed first disclosures of exciting data with important learnings being communicated so the field can advance toward the clinic.  Expect exclusive data from KOLs on the most recent developments in ADAR, APOBEC, CRISPR-Cas13, Cas7-11, and exon editing.

Join 60+ global leaders and scientific experts provided an end-to-end roadmap to ensure the successful delivery of safe, selective and effective RNA editing, discussing topics on:

• Optimized delivery of RNA editing – Sapreme Technologies, Feldan Therapeutics and Nebraska Medical Center will explore the recent advancements in delivering the RNA editing machinery to target cells to minimize off target effects and improve effectivity
• Enhanced chemical modifications – ProQR, MIT and Wave Life Sciences will discuss the impact of chemical modifications on the potency of RNA editing oligos to improve durability and efficiency and enable novel applications of RNA editing

• Integrated machine learning (ML) – Korro Bio, Shape Therapeutics and Ascidian Therapeutics will shed light on how to navigate ML and computational models for de novo guide RNA design and exon editing to enable target discovery and efficient editing